Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Authors :: Burton DR
Desrosiers RC
Doms RW
Feinberg MB
Gallo RC
Hahn B
Hoxie JA
Hunter E
Korber B
Landay A
Lederman MM
Lieberman J
McCune JM
Moore JP
Nathanson N
Picker L
Richman D
Rinaldo C
Stevenson M
Watkins DI
Wolinsky SM
Zack JA
Source :: Science (New York, N.Y.) [Science] 2004 Jan 16; Vol. 303 (5656), pp. 316.
Publication Year :: 2004

Subjects :: Costs and Cost Analysis
HIV Infections prevention & control
HIV Infections therapy
Humans
Immunization Schedule
Immunization, Secondary
T-Lymphocytes, Cytotoxic immunology
T-Lymphocytes, Helper-Inducer immunology
Thailand
United States
Vaccines, Synthetic immunology
AIDS Vaccines immunology
Clinical Trials, Phase III as Topic economics
HIV Envelope Protein gp120 immunology
HIV Infections immunology
HIV-1 immunology

Full Text Access

Tools